NAD DEPENDENT HYDROXYMETHYLGLUTARYL COA REDUCTASES

\ˌɛnˌe͡ɪdˈiː dɪpˈɛndənt hˈa͡ɪdɹəksˌa͡ɪmθɪlɡlˌuːtɑːɹˌɪl kˈə͡ʊ ɐ ɹɪdˈʌkte͡ɪsɪz], \ˌɛnˌe‍ɪdˈiː dɪpˈɛndənt hˈa‍ɪdɹəksˌa‍ɪmθɪlɡlˌuːtɑːɹˌɪl kˈə‍ʊ ɐ ɹɪdˈʌkte‍ɪsɪz], \ˌɛ_n_ˌeɪ_d_ˈiː d_ɪ_p_ˈɛ_n_d_ə_n_t h_ˈaɪ_d_ɹ_ə_k_s_ˌaɪ_m_θ_ɪ_l_ɡ_l_ˌuː_t_ɑː_ɹ_ˌɪ_l k_ˈəʊ ɐ ɹ_ɪ_d_ˈʌ_k_t_eɪ_s_ɪ_z]\

Definitions of NAD DEPENDENT HYDROXYMETHYLGLUTARYL COA REDUCTASES

Sort: Oldest first
 
2010 - Medical Dictionary Database
By DataStellar Co., Ltd

Word of the day

Proto Oncogene Proteins c erbB 2

  • cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.
View More